We undertake primary market research as well as review customer feedback and pain points available in social media or other providers of such information to gather insights to provide a detailed customer analysis, often helping to determine ICP for our clients.
The life sciences & healthcare industry needs to track the changes in customer preferences for information sources, influencing factors in decision-making and socio-economic trends, and the reasons for preference for certain brands, products, or services. These insights help our clients to optimize product development, position their products before customers in a better manner, and optimize their go-to-market strategy. Our customers also use these insights to empower their sales and marketing teams to compete better by deeply rooting their strategy execution based on reliable intelligence on their customers.
We help our clients to compare themselves with competitors and identify their areas of strengths, weaknesses, and areas for improvement, allowing them to enhance their brand positioning and reputation management strategies.
We help our clients understand customers’ needs by gathering feedback from current and potential customers. These assessments can help understand the pain points, challenges, and requirements of life sciences & healthcare providers, researchers, and payers to align products and services accordingly.
We help uncover changes in the customer journey from interest, information gathering, and purchase, as well as identify the stakeholders involved as influencers, decision-makers, and end users to provide valuable insights to help our clients better position their services to their current and prospective customers.
Why SGA
Industry Leaders
SGA thrives by its brand promise Lifes Possible and is recognized as the trusted life sciences & healthcare business consulting and services provider company in the U.S.
12+ Languages
Multilingual capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English (U.S. & U.K.) experts (either in-house or partnerships).
Data-Driven Insights
With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.
End-To-End Solutioning
The in-house KOL capability of more than 700, along with in-house capabilities of primary market research, financial research, data analytics, engineering, IT, and ESG research and consulting, helps to present credible competitive information.
Whitepapers
Emergence of Novel Immune - Mediated Therapies
Immunotherapy has emerged as a promising treatment for cancer, with immune checkpoint inhibitors (ICIs) dominating the market. The market is projected to...
Whitepapers
Future Trends and Technological Advances in Vaccine and Disease Prevention
The introduction of vaccines for key diseases, such as meningococcal meningitis A, hepatitis E, and malaria, in recent years has helped to reduce mortality...
Whitepapers
Market Entry in 2023: Why Must You Also Look at Markets Other Than the US and Japan?
Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities...
CASE STUDIES
We strongly believe in equal opportunity for all. Our research team consists of more females than males i.e., 55 % females, and consists of PhDs, M Pharms, D Pharms, Postgraduate in finance, Biotech postgraduates, and MBAs.
